Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
2.

Apolipoprotein B: novel indicator of elevated intraocular pressure.

Son JH, Chung YK, Son JS.

Eye (Lond). 2015 Oct;29(10):1315-20. doi: 10.1038/eye.2015.37. Epub 2015 Mar 20.

3.

Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.

Hayashi T, Koba S, Ito Y, Hirano T.

Lipids Health Dis. 2017 Jan 26;16(1):21. doi: 10.1186/s12944-017-0417-6.

4.

Estimation of LDL Particle Size Using Lipid Indices: A Population-Based Study of 1578 Schoolchildren.

Watabe Y, Arisaka O, Miyake N, Ichikawa G, Koyama S, Shimura N.

Metab Syndr Relat Disord. 2015 Dec;13(10):465-9. doi: 10.1089/met.2015.0054. Epub 2015 Oct 15.

PMID:
26469303
5.

Assessment of serum apolipoprotein B and apolipoprotein A-1 and their ratio in healthy full term small for gestational age newborns.

Agrawal A, Shrivastava J, Dwivedi R, Siddiqui M.

J Neonatal Perinatal Med. 2017;10(1):49-53. doi: 10.3233/NPM-1672.

PMID:
28304324
6.

High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.

Barkas F, Elisaf M, Liberopoulos E, Liontos A, Rizos EC.

Atherosclerosis. 2016 Apr;247:58-63. doi: 10.1016/j.atherosclerosis.2016.02.001. Epub 2016 Feb 10.

PMID:
26868509
7.

A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.

Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.

Int J Fertil Menopausal Stud. 1994 Sep-Oct;39(5):283-91.

PMID:
7820162
8.
9.

Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.

Pencina MJ, D'Agostino RB, Zdrojewski T, Williams K, Thanassoulis G, Furberg CD, Peterson ED, Vasan RS, Sniderman AD.

Eur J Prev Cardiol. 2015 Oct;22(10):1321-7. doi: 10.1177/2047487315569411. Epub 2015 Jan 29.

PMID:
25633587
10.

Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile.

Kaneva AM, Potolitsyna NN, Bojko ER.

Arch Physiol Biochem. 2017 Feb;123(1):16-22. doi: 10.1080/13813455.2016.1195411. Epub 2016 Jun 27.

PMID:
27347637
11.

Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, Vaduganathan M, Rao RS, Koschinsky M, Morrisett JD.

J Lipid Res. 2001 Apr;42(4):631-8.

12.

Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.

Farnier M, Guyton JR, Jensen E, Polis AB, Johnson-Levonas AO, Brudi P.

Atherosclerosis. 2013 Aug;229(2):415-22. doi: 10.1016/j.atherosclerosis.2013.05.010. Epub 2013 Jun 5.

PMID:
23880197
13.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

14.

Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Metabolism. 2000 Jan;49(1):53-61.

PMID:
10647064
15.

Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels.

Bairaktari E, Hatzidimou K, Tzallas C, Vini M, Katsaraki A, Tselepis A, Elisaf M, Tsolas O.

Clin Biochem. 2000 Oct;33(7):549-55.

PMID:
11124340
18.

Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.

Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM.

Atherosclerosis. 2011 Dec;219(2):596-602. doi: 10.1016/j.atherosclerosis.2011.08.001. Epub 2011 Aug 7.

19.

Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Soran H, France MW, Kwok S, Dissanayake S, Charlton-Menys V, Younis NN, Durrington PN.

Ann Clin Biochem. 2011 Nov;48(Pt 6):566-71. doi: 10.1258/acb.2011.010277. Epub 2011 Oct 17.

PMID:
22006975
20.

An equation to estimate the concentration of serum apolipoprotein B.

Hwang YC, Ahn HY, Lee WJ, Park CY, Park SW.

PLoS One. 2012;7(12):e51607. doi: 10.1371/journal.pone.0051607. Epub 2012 Dec 19.

Supplemental Content

Support Center